Related Experiment Video
Updated: May 31, 2026
07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
[Relationship between RAD51-G135C/XRCC3-C241T polymorphisms and development of acute myeloid leukemia with recurrent
Lin Yang1, Liang Liu, Ying-chang Mi
1Institute of Hematology and Blood Diseases Hospital, Tianjin 300020, China.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|July 7, 2011
Summary
The XRCC3-C241T variant and RAD51-G135C homozygote-type significantly increase acute myeloid leukemia (AML) risk, particularly with the inv(16)/CBFβ-MYH11 genetic subtype. These DNA repair gene polymorphisms are key factors in AML development.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Context:
- Acute myeloid leukemia (AML) is a heterogeneous cancer with various genetic subtypes.
- DNA repair mechanisms, including homologous recombination (HR), play a crucial role in maintaining genomic stability.
- Polymorphisms in HR genes may influence cancer susceptibility and development.
Purpose:
- To investigate the association between RAD51-G135C and XRCC3-C241T polymorphisms in DNA homologous recombination repair genes and the risk of developing acute myeloid leukemia (AML) with specific recurrent chromosome translocations.
- To analyze the impact of these genetic variants on the risk of AML subtypes, particularly those involving the CBFβ-MYH11 fusion gene.
Summary:
- Genomic DNA from 625 de novo AML patients, 806 family members, and 704 volunteers was analyzed for RAD51-G135C and XRCC3-C241T genotypes using PCR-RFLP.
- The XRCC3-C241T variant showed a significantly increased risk (6.22-6.99 fold) for AML with inv(16)/t(16;16)/CBFβ-MYH11.
- The RAD51-G135C homozygote-type (C/C) also showed a slight increase in risk for this AML subtype, while no correlation was found with other AML subtypes like t(15;17) or t(8;21).
Impact:
- Identifies specific DNA repair gene polymorphisms (XRCC3-C241T and RAD51-G135C) as significant risk factors for a particular subtype of acute myeloid leukemia.
- Provides insights into the genetic basis of AML development and the role of homologous recombination repair in leukemogenesis.
- May inform future risk stratification and personalized medicine approaches for AML patients based on genetic profiles.
